Introduction Ethylene oxide (EO) is an important industrial chemical and gaseous sterilant (1). EO is positive in routine genotoxicity
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© Oxford University Press studies and causes cancer in laboratory animals (1) . EO is currently classified by the IARC as a known human carcinogen, and is regulated for occupational exposure at 1 p.p.m. in many countries (1) . The IARC classification was based on limited epidemiology and positive genotoxicity data in humans and rodents, rather than sufficient evidence in epidemiological studies. The supporting evidence from the human biomarker studies used sister chromatid exchanges (SCE), chromosomal aberrations and micronuclei, which are not chemical specific (2) (3) (4) (5) . Epidemiological studies showed that cancer mortality was weakly, inconclusively or not associated with EO exposure in studies of 28 900 US workers, even though 86% of this cohort had their first exposure to EO during or before 1977 when EO was regulated at 50 p.p.m. (6) (7) (8) (9) . Due to limited quantitati ve exposure data in epidemiological studies and the lack of chemical specificity of SCE, chromosomal aberrations and micronuclei, the risk for human carcinogenicity at low EO exposures is associated with considerable uncertainty.
Carcinogenesis is considered a multistage process. Among the earliest cellular changes caused by chemical carcinogens is the formation of DNA adducts, which may play an important role in the initiation and progression of carcinogenesis (10) . Molecular dosimetry of DNA adducts in experimental animals can provide essential information on the relationships between exposure and effect and may permit extension of the observable range for relevant scientific information to concentrations lower than can be achieved in carcinogenesis bioassays (11, 12) . N7-(2-hydroxyethyl)guanine (7-HEG) is the major EO-induced adduct formed in vitro and in vivo (13, 14) . Alkylation at N7 of guanine, with subsequent production of abasic sites by spontaneous or enzymatic depurination, may promote base substitutions, frameshift mutations or large deletions (15, 16) . The dose-response relationships for 7-HEG were reported to be linear in mice and rats repeatedly exposed to EO from 10 to 100 p.p.m. and sublinear from 100 to 300 p.p.m. in rats (13) . At exposures below 10 p.p.m. in rats and 33 p.p.m. in mice, adduct measurements were uncertain or not reported due to the limitations of sensitivity and specificity of the previous assays (13, 17, 18) .
In addition to exogenous sources, 7-HEG is also derived from endogenously formed EO arising from metabolism of ethylene generated by intestinal bacteria, lipid peroxidation of unsaturated fats, hemin and methionine (19) . Previous studies have shown that endogenous 7-HEG is present in rodent tissues, but the amounts reported were near the limit of detection of the assays used (13, 20) . The objective of this study was to utilize a highly sensitive and specific assay, using gas chromatography coupled with high-resolution mass spectrometry (GC-HRMS), to specifically quantitate endogenous and EO-induced 7-HEG. Specific quantitation of 7-HEG in DNA of rodents at low as well as high EO exposures will better characterize this adduct as a biomarker for experimental animal and human biological monitoring studies and clarify its dose-response relationships at low exposures (12) . 
Materials and methods

Chemicals
DNA isolation
DNA was extracted from the whole lung, spleen and brain, or up to 2 g of liver from rats and mice using an automated phenolic extraction procedure (13) . Briefly, DNA was isolated by one phenol-chloroform extraction, two chloroform extractions and isopropanol precipitation using a 340A Nucleic Acid Extractor (Applied Biosystems, Foster City, CA). DNA pellets were dissolved overnight in 3-4 ml of sterilized distilled deionized water at 4°C. These DNA solutions were homogenized by shearing through a 20 gauge needle connected to a 5 ml syringe. DNA concentrations were analyzed using a UV 160U spectrophotometer (Shimadzu, Columbia, MD) and calculated using calf thymus DNA as a standard and from the equation: DNA concentration = 50 ug/ml x absorbance at 260 nmXdilution factor (13).
DNA content was further characterized for each sample by guanine analysis. Twenty microliters of DNA solution were removed from each sample and hydrolysed in 500 ul of 0.1 N HCl solution at 70°C for 30 min. Guanine concentrations were determined with HPLC using an Alltech (Deerfield, IL) strong cation exchange column (250x4.6 mm; 10 urn) and 0.1 M ammonium formate, 100/0 methanol (pH 2.8) as the mobile phase with a flow rate of 1.8 mllmin and an Applied Biosystem UV detector (Ramsey, NJ) with the wavelength set at 254 nm (13) .
Derivatization and quantitation of 7-HEG
The DNA samples were derivatized according to Saha et al. (21) , with minor modifications (22) . DNA samples (10-300 ug) were spiked with 0.1 pmol [ 13 C 4 ]7-HEG . Each sample was dried in a Speed-Vac (Savant model SVCIOO; Farmingdale, NY) and dissolved in HPLC-grade water at 4°C overnight. 7-HEG was released from the DNA backbone using neutral thermal hydrolysis (at 100°C for 15 min). Each sample was immediately placed in an ice bath, treated with 150 JlI of 1 N cold HCI solution and centrifuged at 1200 g and O°C for 15 min using a Sorvall Instruments RC5C centrifuge (DuPont, Wilmington, DE). The DNA backbone was washed with 100 JlI of 1 N cold HCI solution and centrifuged a second time. Both supernatants from each sample were combined and dried under vacuum, and 7-HEG was converted to N7-(2-hydroxyethy1)xanthine by the reaction with tert-butylnitrite in 6 N HCl solution (degassed with nitrogen). Then, each sample was dried in vacuo. Each residue was subjected to liquid-liquid extraction using ethyl acetate and water. The aqueous phase was dried in vacuo. Each residue was reacted with 150 JlI of 10% PFBBr in acetonitrile and 5 mg K 2C03 (dehydrated at 60°C at least 1 h) at room temperature for 20 h, followed by evaporation under nitrogen at 85°C. Each sample was further derived with 10 ul PFBBr in 150 ul dichloromethane and 50 JlI of 1 mg/ul BU4NHS04 in 1 N KOH at room temperature for 20 h. The sample was then dried with nitrogen at 45°C and extracted three times with ethyl acetate. The combined supernatants were dried with nitrogen at 85°C. The residue was dissolved in 50% ethyl acetate/ hexane solution and subjected to solid-phase extraction using silica gel (EM Science, Darmstadt, Germany; particles sizes: 0.063-0.2 mm). The eluent 1788 was dried under nitrogen at 85°C and raised in dry toluene for quantitation. The derivatized samples were quantitated using a Hewlett-Packard 5890 gas chromatograph connected to the mass spectrometer with a J & W Scientific (Folsom, CA) DB-5 ms capillary column (15 m, 0.32 mm and 0.1 urn film thickness). The mass spectrometer was a VG 70,250SEQ operated in the selective-ion-monitoring (SIM) mode and tuned to achieve a resolving power of 10000 using perfluorotributylamine (CF-43; Scientific Instrument Services, Ringoes, NJ) as a calibration reagent as described previously (22, 23) . Helium was used as a carrier gas and the head pressure was set at 10 p.s.i. The source temperature was set at 250°C and methane (5X 10-5 mbar) was used as the reagent gas for electron capture negative chemical ionization. One microliter of derivatized sample was injected through a tight-press injection liner. The GC temperature was increased from 70 to 300°C over 10 min and held for 3 min to evaporate residues from the injected sample. The isotope dilution method was used to determine 7-HEG by monitoring mlz 555.0515 (analyte) and mlz 559.0649 (internal standard). Quantitation of 7-HEG was based on the ratio of the peak area of the analyte to that of the internal standard and comparison with a calibration curve for 7-HEG (22) .
Statistical analysis
The one-way Student's t-test was used to evaluate differences in amounts of 7-HEG between controls and EO-exposed rodents. The null hypothesis, that means of 7-HEG were equal, was rejected at P < 0.05. Linear regression was used to fit the dose-response relationships for 7-HEG in tissues of rodents using SAS software.
Results
Previous methods for measuring 7-HEG have been limited in both specificity and sensitivity. This study utilizes a newly developed method that couples electrophore labeling with GC-HRMS for the measurement of 7-HEG (22) . The sensitivity of this method is affected by the yield of deri vatization. Conversion of7-HEG to N7-(2-hydroxyethyl)xanthine by nitrosation increased the derivatization efficiency --2.5-fold (21) . Deri vatization efficiency decreased with the presence of salt (such as ammonium formate and ammonium phosphate). The yield of derivatization went up with an increase of either derivatization time or the amount of PFBBr used. However, reactions between undesirable compounds and PFBBr also were promoted, increasing background. These chemical interferences might overlap with the analyte or internal standard peak so that sensitivity and specificity could drop dramatically. 150 microliters of 10% PFBBr in acetonitrile in the first and 10 J.ll of PFBBr in the second derivatization for 20 h were optimal for the analysis of endogenous 7-HEG. The derivatization efficiency varied from --2.5 to 15% (estimated by the comparison of the peak area of the amount of [ 13C 4]7-HEG spiked in each sample with that of 500 fg of derivatized standard solution).
Quantitation of endogenous 7-HEG
This assay was able to quantitate endogenous 7-HEG with excellent sensitivity, specificity, precision and reproducibility. Figure 1 is a representative chromatogram from spleen DNA of a control rat. Analyses of chromatograms from tissue samples of control animals revealed average background concentrations of 7-HEG varying from 0.2 to 0.3 pmol/umol of guanine in lung, brain, spleen and liver from B6C3Fl mice and F-344 rats (Tables I and II) .
Quantitation of 7-HEG in EO-exposed rodents
The effects of repeated EO exposures on the formation of 7-HEG in DNA of liver, spleen, brain and lung from rats and mice exposed to 3-100 p.p.m. EO are presented in Tables I   and II, and lung of mice) and non-target tissues (liver and lung of rats and liver, spleen and brain of mice) for carcinogenesis (24) (25) (26) . Statistically greater amounts of 7-HEG accumulated in tissues of rats than in mice exposed to the same concentrations of EO (Tables I and II) . These results agree with a previous study that demonstrated tissue and species differences in formation and removal of 7-HEG (13). Repeated exposures to EO produced a similar pattern of dose-response curves in tissues of rats and mice. Doseresponses were linear at exposures between 3 and 100 p.p.m. in the liver, brain, spleen and lung of mice as determined by linear regression analysis (Figure 2 ). However, 7-HEG was significantly higher in lung than liver and spleen of mice exposed to 10-100 p.p.m. EO (P < 0.05). For rats, the doseresponse curves for 7-HEG in all four tissues were linear between 3 and 100 p.p.m. when examined using linear regression ( Figure 3 ). When 7-HEG was compared across tissues, brain and lung exhibited evidence for a slightly sublinear response between 33 and 100 p.p.m. EO. There were significantly greater amounts of 7-HEG in brain and lung than in liver and spleen of rats at 100 p.p.m. EO (P < 0.005). 
a7-HEG in exposed tissue was significantly greater than control (t-test at P < 0.05).
brrhe amounts of 7-HEG in brain and lung were significantly greater than those in liver and spleen (t-test at P < 0.005). 
bThe amounts of 7-HEG in brain and lung were significantly greater than those in liver and spleen (t-test at P < 0.05). 
Endogenous 7-HEG in rodents
Endogenous DNA damage is likely to be involved in spontaneous mutation and cancer formation (33, 34) . As such, knowledge of endogenous 7-HEG may provide a better understanding of background cancer risk. Endogenous levels of 5.6 ± 3.0 pmol 7-HEG/mg DNA have been reported in the white blood cells of Sprague-Dawley rats, and 2-6 pmol adduct/mg DNA in tissues of F344 rats and B6C3Fl mice (13, 18) . Compared with the data in Tables I and II, Swenberg, manuscript submitted for publication). Consideration of these issues may be important in human biological monitoring and risk assessment, since occupational exposures are regulated at 1 p.p.m. EO in many countries; yet the endogenous amounts of 7-HEG in humans are equivalent to that produced by~10 p.p.m. EO in rodents.
7-HEG in EO-exposed rodents
Significant dose-dependent accumulations of 7-HEG at repeated exposures below 33 p.p.rn. of EO were measured in this study. In contrast, significant increases in cancer incidence were not detected at these exposures in 2 year carcinogenicity bioassays (24, 25) . This phenomenon suggests that 7-HEG should be a sensitive biomarker for EO exposures that would be useful for extending the dose-response for biologically based risk assessment. Differences in 7-HEG in target and non-target tissues were not greater than 3-fold and were consistent with efficient pulmonary uptake of EO (13), rapid and even distribution of EO to all tissues, except possibly testis (38) , and the ability of EO to act as a direct alkylating agent (39) . These results agreed with the previous dosimetry study of7-HEG and suggest that the formation of DNA adducts was not the only determining factor in EO carcinogenicity (13) .
Tissue-specific accumulation of 7-HEG represents the summation of EO distribution, detoxification and DNA repair in individual tissues. If one assumes similar rates of chemical depurination across tissues, tissues with greater half-life values of 7-HEG may have lower base excision repair rates, resulting in greater accumulation of 7-HEG. For example, higher 7-HEG in rat lung and brain corresponded to longer half-life values in brain (5.4 days) and lung (5.8 days) than liver (3.9 days) and spleen (2.9 days) of rats (13) . Similar relationships between the amounts of 7-HEG and its half-life values were also true between rats and mice (13) . 
Advantages of the GC-HRMS assay
The main limitations of previous assays for 7-HEG were sensitivity and specificity (27, 28) . 32P-post-Iabeling has comparable sensitivity (0.1-1.0 fmol) with GC-HRMS, but 7-HEG and N7-methylguanine were not completely resolved on the thin-layer chromatography (TLC) plates (29) . Recently, 7-HEG and N7-methylguanine have been separated using TLC and HPLC (30) . In addition, depurination of this adduct must be carefully monitored in the 32P-post-Iabeling assay. Immunoassays often lacked sensitivity and suffered from extensive cross-reactivity of their antibodies with N7-methylguanine (31) . HPLC with fluorescence detection (HPLC-FD) and electrochemical detection (HPLC-ECD) have been unable to routinely quantitate endogenous 7-HEG (13, 32) . Derivation of 7-HEG with N-methyl-trimethylsilyl-trifluoroacetamide was not very stable, and analysis of this derivative using electron impact ionization mass spectrometry (EI-GC/MS) demonstrated a detection limit of~35 fmol on column (20) .
Sensitivity of the present GC-HRMS assay was significantly increased over the EI-GCIMS assay because the addition of three pentafluorobenzyl (PFB) groups dramatically improved adduct volatility, GC separation and efficiency to absorb thermal electrons in the source to specifically generate the most abundant fragment [PFB 2-7-HEG]- (21) (22) (23) . Specificity was significantly improved by using HRMS to eliminate specific and non-specific interferences originating from reagents, complex biological matrixes and/or derivatization steps (23) . Accurate quantitation was based on the ion abundance ratio measurement of the coeluted analyte and a stable isotope-labeled internal standard. This sensitivity and specificity are very important when analyzing trace amounts of DNA adducts produced by very low exposures or arising endogenously.
HPLC-FD with a detection limit of~20 pmol was not able to quantitate 7-HEG in rats exposed to EO concentrations below 10 p.p.m. and in mice exposed to EO below 33 p.p.m. (13) . Furthermore, when DNA from the same tissue samples was analyzed, quantitation of 7-HEG using HPLC-FD showed 1.3-to 2.5-fold higher values than were obtained using GC-HRMS (Tables I and II) . These differences may be in part due to the ability of this GC-HRMS assay to eliminate coeluted interferences, resulting in lower values than the HPLC-FD method.
The linear dose-responses in liver, brain and spleen of mice and liver and spleen of rats suggest that detoxification and DNA repair were not saturated at EO exposures from 3 to 100 p.p.m.. Methylpurine DNA glycosylase (MPG) is thought to be the principal pathway for repair of N7-alkylguanines (40) . Induction of MPG has been observed in cultured cells and rats exposed to DNA-damaging agents (41, 42) , but species differences in repair have not been reported.
Detoxication of EO involves two different pathways: glutathione conjugation and hydrolysis with epoxide hydrolase (43) . The distribution of detoxication enzymes in various tissues could affect detoxication rates and subsequent 7-HEG formation. For example, glutathione content is 4-fold higher in liver than in brain and lung of rats (44) . This lower glutathione content might account for higher amounts of 7-HEG in brain and lung than in liver of rats. The amounts of glutathione have been reported to be depressed by ,..,,20% in liver and lung of F-344 rats exposed to 100 p.p.m. of EO for 4 h (45). Glutathione depletion was also reported to be significant in lung of B6C3F1 mice exposed to~50 p.p.m. EO for 4 h (46). The extent of glutathione depletion and rate of recovery may be important factors in the efficiency of DNA alkylation by EO. The low amounts of epoxide hydrolase in lung suggest that detoxication could be depleted even at the low concentrations of EO employed in this study (45) . Together, the slight slope change of the dose-response curve for 7-HEG in lungs of mice suggests that detoxication may be an important factor in the responses of 7-HEG at concentrations that were carcinogenic.
When the amount of 7-HEG induced by exposure to 3 p.p.m. EO was compared with that present in unexposed control animals, a major difference was found between rats and mice. Rats exposed to 3 p.p.m. EO had 5.3, 12.5, 9.0 and 8.0 times more 7-HEG in liver, spleen, brain and lung, respectively, than was present in the same tissues of unexposed rats. In contrast, mice exposed to 3 p.p.m. EO only had 1.3, 2.5, 2.0 and 1.7 times more 7-HEG in liver, spleen, brain and lung, respectively. The increase in 3 p.p.m. EO mouse liver 7-HEG was not significantly different from controls. This species difference may reflect more efficient detoxication and/or DNA repair of EO in mice. Obtaining similar data for humans would clearly enhance our ability to more accurately predict the effects of low exposures of EO.
Ehrenberg and Tornqvist (47) have suggested that there are two major problems associated with EO research: (i) sensitivity of the analytical methods and (ii) knowledge of the shape of dose-response curves at very low doses. The present study directly addresses these issues. This GC-HRMS method, with superior sensitivity and specificity, can be used to study the dose-response for 7-HEG in tissues of rodents exposed to EO from 0 p.p.m. to the highest exposure used. This advance is possible since the use of GC-HRMS tuned to a resolving power of 10 000 reduces chemical interferences to a minimum (22, 23) . This methodology can be expanded to use [13C 2]EO exposure to accurately determine the relationships between low exposures and endogenous 7-HEG formation. Likewise, interindividual differences in detoxication and DNA repair can be evaluated. Together, such data should significantly improve biologically based risk assessment for EO.
